A Japanese patient with neonatal biotin-responsive basal ganglia disease.


Journal

Human genome variation
ISSN: 2054-345X
Titre abrégé: Hum Genome Var
Pays: England
ID NLM: 101652445

Informations de publication

Date de publication:
29 Sep 2022
Historique:
received: 12 10 2021
accepted: 03 08 2022
revised: 03 08 2022
entrez: 29 9 2022
pubmed: 30 9 2022
medline: 30 9 2022
Statut: epublish

Résumé

Biotin-responsive basal ganglia disease (BBGD) with SLC19A3 mutation was first reported in 1998, and over 30 mutations have been reported. We report a neonatal BBGD case with sudden-onset feeding difficulty and impaired consciousness. Encephalopathy resolved after the initiation of biotin and thiamine treatment. Genetic testing revealed a novel heterozygous mutation [c.384_387del, p.Tyr128fs];[c.265 A > C, p.Ser89Arg] in SLC19A3. Early treatment for BBGD is essential, especially with onset in the neonatal or early infancy period.

Identifiants

pubmed: 36175418
doi: 10.1038/s41439-022-00210-z
pii: 10.1038/s41439-022-00210-z
pmc: PMC9522647
doi:

Types de publication

Journal Article

Langues

eng

Pagination

35

Subventions

Organisme : Japan Agency for Medical Research and Development (AMED)
ID : 21ek0109468,19ek0109273

Informations de copyright

© 2022. The Author(s).

Références

J Hum Genet. 2015 Jul;60(7):381-5
pubmed: 25876998
Eur J Paediatr Neurol. 2018 Nov;22(6):1139-1149
pubmed: 30054086
Eur J Med Genet. 2020 Oct;63(10):104003
pubmed: 32679198
Brain Dev. 2020 Sep;42(8):572-580
pubmed: 32600842
PLoS Genet. 2016 Jan 07;12(1):e1005679
pubmed: 26741492
J Inherit Metab Dis. 2017 Sep;40(5):685-693
pubmed: 28429146
Am J Physiol Gastrointest Liver Physiol. 2004 Mar;286(3):G491-8
pubmed: 14615284
J Inherit Metab Dis. 2019 Jul;42(4):581-597
pubmed: 31095747
Brain. 2016 Jan;139(Pt 1):31-8
pubmed: 26657515
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Ann Clin Transl Neurol. 2019 Oct;6(10):2097-2103
pubmed: 31557427
BMC Med Genet. 2010 Dec 22;11:171
pubmed: 21176162
Am J Physiol Cell Physiol. 2006 Nov;291(5):C851-9
pubmed: 16790503
Brain. 2014 Sep;137(Pt 9):e295
pubmed: 24878502
Pediatrics. 2013 May;131(5):e1670-5
pubmed: 23589815
Brain. 2013 Mar;136(Pt 3):882-90
pubmed: 23423671
Front Genet. 2021 Jul 01;12:683255
pubmed: 34276785
J Cent Nerv Syst Dis. 2017 Oct 27;9:1179573517737521
pubmed: 29123435

Auteurs

Mizuki Kobayashi (M)

Division of Pediatrics, Jichi Medical University, Tochigi, Japan.

Yuichi Suzuki (Y)

Department of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan.

Maki Nodera (M)

Department of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan.

Ayako Matsunaga (A)

Center for Medical Genetics, Department of Metabolism, Chiba Children's Hospital, Chiba, Japan.

Masakazu Kohda (M)

Diagnostics and Therapeutics of Interactable Diseases, Interactable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

Yasushi Okazaki (Y)

Diagnostics and Therapeutics of Interactable Diseases, Interactable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

Kei Murayama (K)

Center for Medical Genetics, Department of Metabolism, Chiba Children's Hospital, Chiba, Japan.

Takanori Yamagata (T)

Division of Pediatrics, Jichi Medical University, Tochigi, Japan.

Hitoshi Osaka (H)

Division of Pediatrics, Jichi Medical University, Tochigi, Japan. hosaka@jichi.ac.jp.

Classifications MeSH